News from REMEDY

Marianne Skaar presents the EULAR recommendations for how user medalians should be involved in research on rheumatic diseases. The recommendations were updated in 2023.

The very first biopsies in the Start project were a starting shot for the operational part of an ambitious research work. If you want, it will make major contributions to diagnostics and treatment for patients with inflammatory arthritis.

Diakonhjemmet foundation now becomes a partner in Health2B and an actor in the arena for health innovation. This marks an important milestone in the development of sustainable solutions for the health services.

How can the healthcare system deal with chronic diseases in the future? Hege Johanne Magnussen has researched this and interviewed patients and healthcare personnel about the course of hand osteoarthritis. What contributes to, and what stands in the way of, the transfer of responsibility, roles and tasks between practitioners and levels in the health service?

In 2024, Diakonhjemmet hospital has set a new record with 14 doctoral degrees in one year. This marks an important milestone in the work for better treatment and health services. It is the result of a long-term commitment to research and innovation for the benefit of patients. Seven of the doctorates come from the REMEDY centre. 

More than 50,000 Norwegians use a common type of medicine to suppress the immune system. A new study shows that these patients no longer have a high risk of severe covid-19.

Conducting clinical trials requires more than just researchers. Support personnel handle rules, applications and documents. They also contribute to good communication in the studies.